Literature DB >> 9243235

Continuous plasma resin perfusion for detoxification of methotrexate.

J Greil1, P A Wyss, K Ludwig, S Bonakdar, J Scharf, J D Beck, H Ruder.   

Abstract

UNLABELLED: Acute renal failure is a rare but very severe side-effect of methotrexate (MTX) treatment requiring extracorporeal detoxification. A new detoxification regime, consisting of a haemodiafiltration (HDF) and continuous plasma resin perfusion (PRP) over anion exchange resin column with high affinity for MTX, was used for treatment of MTX-induced acute renal failure in a 2-year-old boy with medulloblastoma. More than 99% of MTX was removed from plasma by perfusion over the resin column resulting in a marked decrease of MTX plasma half-life. No haematological complications occurred.
CONCLUSION: The use of PRP alone or in combination with HDF is a new and effective treatment strategy for extracorporeal detoxification of MTX.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9243235     DOI: 10.1007/s004310050656

Source DB:  PubMed          Journal:  Eur J Pediatr        ISSN: 0340-6199            Impact factor:   3.183


  3 in total

1.  The utility of online haemodiafiltration in methotrexate poisoning.

Authors:  Mohamed Said Abdelsalam; Mohammed Mahdi Althaf; Osman Alfurayh; Irfan Maghfoor
Journal:  BMJ Case Rep       Date:  2014-05-23

2.  Extracorporeal Treatment for Methotrexate Poisoning: Systematic Review and Recommendations from the EXTRIP Workgroup.

Authors:  Marc Ghannoum; Darren M Roberts; David S Goldfarb; Jesper Heldrup; Kurt Anseeuw; Tais F Galvao; Thomas D Nolin; Robert S Hoffman; Valery Lavergne; Paul Meyers; Sophie Gosselin; Tudor Botnaru; Karine Mardini; David M Wood
Journal:  Clin J Am Soc Nephrol       Date:  2022-03-02       Impact factor: 10.614

3.  Carboxypeptidase-G2 rescue in a patient with high dose methotrexate-induced nephrotoxicity.

Authors:  Eun Sil Park; Kyung Hee Han; Hyoung Soo Choi; Hee Young Shin; Hyo Seop Ahn
Journal:  Cancer Res Treat       Date:  2005-04-30       Impact factor: 4.679

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.